Sofosbuvir, with the CAS number 1190307 - 88 - 0, is a revolutionary antiviral drug in the field of hepatitis C treatment. Our product is factory - supplied, ensuring high - quality and best - price offers for customers.
Basic Information and Parameters:
Sofosbuvir is mainly used for the treatment of hepatitis C virus (HCV) infections. It is a nucleotide analog inhibitor of the HCV NS5B polymerase, which plays a key role in the replication of the virus. By inhibiting this polymerase, sofosbuvir can effectively block the replication process of HCV, thereby reducing the viral load in the patient's body.
It can be used in combination with other antiviral drugs to form a comprehensive treatment regimen, which can significantly improve the cure rate of hepatitis C. This product is suitable for different genotypes of HCV - infected patients, providing a more extensive treatment option for the clinical treatment of hepatitis C.
The usage of sofosbuvir should be strictly in accordance with the doctor's advice. Generally, it is taken orally. The recommended dosage is usually 400 mg once daily. It can be taken with or without food, but it is important to maintain a regular dosing schedule to ensure the stability of drug concentration in the body.
During the treatment process, patients need to regularly monitor their liver function, viral load and other indicators to evaluate the treatment effect. If any adverse reactions occur, such as nausea, fatigue, headache, etc., patients should inform their doctor in time, and the doctor will adjust the treatment plan according to the specific situation.
Case 1: Mr. Smith, a 45 - year - old male, was diagnosed with hepatitis C genotype 1. He started a treatment course with sofosbuvir in combination with ribavirin. After 12 weeks of treatment, his HCV RNA level dropped below the detectable limit, indicating a significant reduction in viral load. After 24 weeks of continuous treatment, he achieved a sustained virological response (SVR), which means that the hepatitis C virus was completely cleared from his body. His liver function also gradually returned to normal, and he no longer showed symptoms such as fatigue and jaundice.
Case 2: Ms. Johnson, a 38 - year - old female with hepatitis C genotype 3, received a treatment regimen of sofosbuvir and daclatasvir. She took sofosbuvir 400 mg once daily as prescribed. After 8 weeks of treatment, her HCV RNA level decreased significantly. By the end of the 16 - week treatment, she also achieved SVR. Her liver function improved, and she was able to return to her normal work and life.
If you have any questions about our Factory Supply Sofosbuvir Cas 1190307 - 88 - 0, please feel free to contact us.
Este é o William, Diretor Executivo da Zhishang Chemical Co., Ltd.
Bem-vindo a visitar a nossa fábrica. Como o principal fabricante de produtos químicos, temos nos esforçado para a qualidade do produto, inovação, P & D e atendimento ao cliente nos últimos 7 anos. Nos próximos 10 anos ou mais, estamos empenhados em nos tornarmos o fornecedor de produtos químicos mais confiável do mundo, criando uma marca internacional bem conhecida e de confiança dos clientes, com o espírito de "um metro de largura, dez mil metros de profundidade", continuamos a nos concentrar na pesquisa e desenvolvimento de produtos, continuamos a nos concentrar no atendimento ao cliente, continuamos a melhorar o sistema de serviço da cadeia de suprimentos, para criar uma equipe profissional de serviços de fornecimento de produtos químicos, para alcançar uma cooperação de longo prazo ganha-ganha. Por favor, não hesite em contactar-nos se tiver alguma dúvida.
Portuguese 
English (United States) 
English (Australia) 
Spanish